Paolini John F相关文献与解析，生知库 | 链接生命科学的每一步

IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCE

IL-1通路抑制在复发性心包炎治疗中的应用：RESONANCE研究中皮质类固醇减量方案的真实世界应用

doi:10.1016/j.jacadv.2025.102050

Cremer, Paul C; Luis, Sushil A; Garshick, Michael S; Raisinghani, Ajit; Weber, Brittany; Winnowski, Dona; Clair, JoAnn; Parameswaran, Vidhya; Curtis, Allison; Klein, Allan L; Paolini, John F

信号转导

发表日期：2025

文献求助收藏

Longitudinal cardiac magnetic resonance imaging following clinical response to rilonacept and prior to recurrence upon treatment suspension: a RHAPSODY subgroup analysis

利洛纳塞普治疗后出现临床反应且停药后复发前进行的纵向心脏磁共振成像：RHAPSODY 亚组分析

期刊:European Heart Journal-Cardiovascular Imaging

影响因子:6.6

doi:10.1093/ehjci/jeae200

Cremer, Paul C; Brucato, Antonio; Insalaco, Antonella; Lin, David; Luis, Sushil A; Kwon, Deborah H; Jellis, Christine L; Clair, JoAnn; Curtis, Allison; Wang, Sheldon; Klein, Allan L; Imazio, Massimo; Paolini, John F

发表日期：2024

文献求助收藏

Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept

长期使用利洛纳塞普可持续降低心包炎复发风险

期刊:Journal of the American Heart Association

影响因子:5.3

doi:10.1161/JAHA.123.032516

Imazio, Massimo; Klein, Allan L; Brucato, Antonio; Abbate, Antonio; Arad, Michael; Cremer, Paul C; Insalaco, Antonella; LeWinter, Martin M; Lewis, Basil S; Lin, David; Luis, Sushil A; Nicholls, Stephen J; Sutej, Paul; Wasserstrum, Yishay; Clair, JoAnn; Agarwal, Indra; Wang, Sheldon; Paolini, John F

发表日期：2024

文献求助收藏

Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension

接受利洛纳塞普治疗的 COVID-19 合并 SARS-CoV-2 疫苗接种患者未出现心包炎复发：RHAPSODY 长期扩展研究结果

期刊:CJC Open

影响因子:1.9

doi:10.1016/j.cjco.2024.02.002

Brucato, Antonio; Trotta, Lucia; Arad, Michael; Cremer, Paul C; Insalaco, Antonella; Klutstein, Marc; LeWinter, Martin; Lin, David; Luis, Sushil A; Wasserstrum, Yishay; Clair, JoAnn; Wang, Sheldon; Klein, Allan L; Imazio, Massimo; Paolini, John F

SARS-CoV-2

发表日期：2024

文献求助收藏

Reply to Albulushi et al.-Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From RHAPSODY Long-term Extension

回复 Albulushi 等人——接受 Rilonacept 治疗的 COVID-19 合并 SARS-CoV-2 疫苗接种患者未发生心包炎复发：RHAPSODY 长期扩展研究结果

期刊:CJC Open

影响因子:1.9

doi:10.1016/j.cjco.2024.05.014

Brucato, Antonio; Klein, Allan L; Imazio, Massimo; Paolini, John F

SARS-CoV-2

发表日期：2024

文献求助收藏

Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report

基因工程猪-人异种心脏移植同情用药中移植物功能障碍：病例报告

期刊:Lancet

影响因子:88.5

doi:10.1016/S0140-6736(23)00775-4

Mohiuddin, Muhammad M; Singh, Avneesh K; Scobie, Linda; Goerlich, Corbin E; Grazioli, Alison; Saharia, Kapil; Crossan, Claire; Burke, Allen; Drachenberg, Cinthia; Oguz, Cihan; Zhang, Tianshu; Lewis, Billeta; Hershfeld, Alena; Sentz, Faith; Tatarov, Ivan; Mudd, Sarah; Braileanu, Gheorghe; Rice, Kathryn; Paolini, John F; Bondensgaard, Kent; Vaught, Todd; Kuravi, Kasinath; Sorrells, Lori; Dandro, Amy; Ayares, David; Lau, Christine; Griffith, Bartley P

发表日期：2023

文献求助收藏

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

人源单克隆抑癌素M受体β抗体vixarelimab治疗中重度结节性痒疹的疗效和安全性：一项随机、双盲、安慰剂对照的2a期研究

期刊:EClinicalMedicine

影响因子:10

doi:10.1016/j.eclinm.2023.101826

Sofen, Howard; Bissonnette, Robert; Yosipovitch, Gil; Silverberg, Jonathan I; Tyring, Stephen; Loo, Wei Jing; Zook, Matthew; Lee, Mark; Zou, Liangxing; Jiang, Guang-Liang; Paolini, John F

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis

在复发性心包炎患者中，从口服疗法过渡到利洛纳塞普单药治疗

期刊:Heart

影响因子:4.4

doi:10.1136/heartjnl-2022-321328

Brucato, Antonio; Wheeler, Alistair; Luis, Sushil Allen; Abbate, Antonio; Cremer, Paul C; Zou, Liangxing; Insalaco, Antonella; Lewinter, Martin; Lewis, Basil S; Lin, David; Nicholls, Stephen; Pancrazi, Massimo; Klein, Allan L; Imazio, Massimo; Paolini, John F

发表日期：2023

文献求助收藏

Vixarelimab in Patients With Prurigo Nodularis: A Randomized Clinical Trial

Vixarelimab治疗结节性痒疹患者：一项随机临床试验

Th2 mRNA gene expression analysis separates Prurigo nodularis into two immune signature groups.

Th2 mRNA 基因表达分析将结节性痒疹分为两个免疫特征组。

IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCE

IL-1通路抑制在复发性心包炎治疗中的应用：RESONANCE研究中皮质类固醇减量方案的真实世界应用

Longitudinal cardiac magnetic resonance imaging following clinical response to rilonacept and prior to recurrence upon treatment suspension: a RHAPSODY subgroup analysis

利洛纳塞普治疗后出现临床反应且停药后复发前进行的纵向心脏磁共振成像：RHAPSODY 亚组分析

Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept

长期使用利洛纳塞普可持续降低心包炎复发风险

Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension

接受利洛纳塞普治疗的 COVID-19 合并 SARS-CoV-2 疫苗接种患者未出现心包炎复发：RHAPSODY 长期扩展研究结果

Reply to Albulushi et al.-Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From RHAPSODY Long-term Extension

回复 Albulushi 等人——接受 Rilonacept 治疗的 COVID-19 合并 SARS-CoV-2 疫苗接种患者未发生心包炎复发：RHAPSODY 长期扩展研究结果

Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report

基因工程猪-人异种心脏移植同情用药中移植物功能障碍：病例报告

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

人源单克隆抑癌素M受体β抗体vixarelimab治疗中重度结节性痒疹的疗效和安全性：一项随机、双盲、安慰剂对照的2a期研究

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis

在复发性心包炎患者中，从口服疗法过渡到利洛纳塞普单药治疗